Improvements in clinical response between 12 and 24 weeks in patients with rheumatoid arthritis on etanercept therapy with or without methotrexate

BACKGROUND: Whereas many patients respond quickly to treatment with tumour necrosis factor (TNF) inhibitors, some patients may experience significant but delayed responses. OBJECTIVE: To evaluate the clinical response between 12 and 24 weeks in subjects with rheumatoid arthritis from the Trial of Et...

Descripción completa

Detalles Bibliográficos
Autores principales: Kavanaugh, A, Klareskog, L, van der Heijde, D, Li, J, Freundlich, B, Hooper, M
Formato: Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2008
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2566536/
https://www.ncbi.nlm.nih.gov/pubmed/18535115
http://dx.doi.org/10.1136/ard.2008.094524

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2566536/
https://www.ncbi.nlm.nih.gov/pubmed/18535115
http://dx.doi.org/10.1136/ard.2008.094524

Ejemplares similares